Nicholas S. McCarty

Nicholas S. McCarty

Auto-generated profile, based on publicly available information

Nicholas S. McCarty

Fraternal Order of Eagles Diabetes Research Center and

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Trends in Biotechnology
Verified
Journal Article
Open access
NMNicholas S. McCarty
Nicholas S. McCarty
Rodrigo Ledesma-AmaroRodrigo Ledesma-Amaro
Rodrigo Ledesma-Amaro
Microbial consortia have been used in biotechnology processes, including fermentation, waste treatment, and agriculture, for millennia. Today, synthetic biologists are increasingly engineering microbial consortia for diverse applications, including the bioproduction of medicines, biofuels, and biomaterials from inexpensive carbon sources. An improved understanding of natural microbial ecosystems, and the development of new tools to construct synthetic consortia and program their behaviors, will vastly expand the functions that can be performed by communities of interacting microorganisms. Here, we review recent advancements in synthetic biology tools and approaches to engineer synthetic microbial consortia, discuss ongoing and emerging efforts to apply consortia for various biotechnological applications, and suggest future applications.

9 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
NMNicholas S. McCarty
Nicholas S. McCarty
AGAlicia E. Graham
Alicia E. Graham
LSLucie Studená
Lucie Studená
Rodrigo Ledesma-AmaroRodrigo Ledesma-Amaro
Rodrigo Ledesma-Amaro
Multiplexed CRISPR technologies, in which numerous gRNAs or Cas enzymes are expressed at once, have facilitated powerful biological engineering applications, vastly enhancing the scope and efficiencies of genetic editing and transcriptional regulation. In this review, we discuss multiplexed CRISPR technologies and describe methods for the assembly, expression and processing of synthetic guide RNA arrays in vivo. Applications that benefit from multiplexed CRISPR technologies, including cellular recorders, genetic circuits, biosensors, combinatorial genetic perturbations, large-scale genome engineering and the rewiring of metabolic pathways, are highlighted. We also offer a glimpse of emerging challenges and emphasize experimental considerations for future studies.

2 April 2019 in ACS Synthetic Biology
Verified
Journal Article
Closed access
NMNicholas S. McCarty
Nicholas S. McCarty
WSWilliam M. Shaw
William M. Shaw
TETom Ellis
Tom Ellis
Rodrigo Ledesma-AmaroRodrigo Ledesma-Amaro
Rodrigo Ledesma-Amaro

26 March 2020 in JCI Insight
Verified
Journal Article
Closed access
PDF file
CRChristian Riehle
Christian Riehle
EWEric T. Weatherford
Eric T. Weatherford
AWAdam R. Wende
Adam R. Wende
BJBharat P. Jaishy
Bharat P. Jaishy
ASAlec W. Seei
Alec W. Seei
EAE. Dale Abel
E. Dale Abel
Pressure overload (PO) cardiac hypertrophy and heart failure are associated with generalized insulin resistance and hyperinsulinemia, which may exacerbate left ventricular (LV) remodeling. While PO activates insulin receptor tyrosine kinase activity that is transduced by insulin receptor substrate 1 (IRS1), the present study tested the hypothesis that IRS1 and IRS2 have divergent effects on PO-induced LV remodeling. We therefore subjected mice with cardiomyocyte-restricted deficiency of IRS1 (CIRS1KO) or IRS2 (CIRS2KO) to PO induced by transverse aortic constriction (TAC). In WT mice, TAC-induced LV hypertrophy was associated with hyperactivation of IRS1 and Akt1, but not IRS2 and Akt2. CIRS1KO hearts were resistant to cardiac hypertrophy and heart failure in concert with attenuated Akt1 activation. In contrast, CIRS2KO hearts following TAC developed more severe LV dysfunction than WT controls, and this was prevented by haploinsufficiency of Akt1. Failing human hearts exhibited isoform-specific IRS1 and Akt1 activation, while IRS2 and Akt2 activation were unchanged. Kinomic profiling identified IRS1 as a potential regulator of cardioprotective protein kinase G–mediated signaling. In addition, gene expression profiling revealed that IRS1 signaling may promote a proinflammatory response following PO. Together, these data identify IRS1 and Akt1 as critical signaling nodes that mediate LV remodeling in both mice and humans.

1 March 2017 in Cardiovascular Pathology
Verified
Journal Article
Closed access
CRChristian Riehle
Christian Riehle
GSGesine M. Scharf
Gesine M. Scharf
JSJan-Thorben Sieweke
Jan-Thorben Sieweke
FZFlorian Zauner
Florian Zauner
UFUlrike Flierl
Ulrike Flierl
MWMechthild Westhoff-Bleck
Mechthild Westhoff-Bleck

7 August 2022
Verified
Report
Closed access
NMNicholas McCarty
Nicholas McCarty